IGKV1D-22 and coronary artery disorder: Recently, it has been shown that the expression of S100A8/A9 was high in human atherosclerotic lesions, and the blood levels were also on the rise among the patients with coronary artery diseases (CAD), suggesting implied S100A8/A9 might act as a biomarker for cardiovascular events (26).